IP Library Granted Patent US 9,045,418
Granted Patent B2
US 9,045,418 · App. 14/323,587 · Granted Jun 2, 2015

Compounds, compositions and methods for treatment and prevention of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,045,418
App. No.
14/323,587
Granted
Jun 2, 2015
Kind
B2
Abstract

Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the orthopoxvirus.

Claims (17)

1. A process for producing N-[(3aR,4S,4aS,5aR,6R,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide comprising the steps of:

(a) reacting 4-trifluoromethylbenzhydrazide with a compound of formula

in a solvent to form a reaction product; and

b) collecting N-[(3aR,4S,4aS,5aR,6R,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide.

2. The process of claim 1 , wherein the ratio of compound 1(b) to 4-trifluoromethylbenzhydrazide is 0.89 to 1.

3. The process of claim 1 , wherein the solvent is ethanol.

4. The process of claim 1 , wherein the reaction occurs at above room temperature.

5. The process of claim 1 , wherein the reaction occurs under argon.

6. The process of claim 1 , wherein the solvent is removed by evaporation.

7. The process of claim 1 , wherein N-[(3aR,4S,4aS,5aR,6R,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide is further purified by chromatography.

8. A method of making N-[(3aR,4S,4aS,5aR,6R,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide, said method comprising:

a) reacting cycloheptatriene and maleic anhydride in a first solvent to form a compound of formula

b) collecting compound 1(b);

c) reacting 4-trifluoromethylbenzhydrazide with said compound 1(b) in a second solvent to form N-[(3aR,4S,4aS,5aR,6R,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide; and

d) collecting N-[(3aR,4S,4aS,5aR,6R,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide.

9. The method of claim 8 , wherein said first solvent comprises xylenes.

10. The method of claim 8 , wherein said second solvent is ethanol.

Assignments (3)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 40349/0219 Recorded Mar 13, 2020
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 052163/0014 →
SECURITY INTEREST Recorded Nov 16, 2016
From: SIGA TECHNOLOGIES, INC.
To: CORTLAND CAPITAL MARKET SERVICES, LLC
Reel/Frame 040349/0219 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2014
From: JORDAN, ROBERT; BAILEY, THOMAS R.; RIPPIN, SUSAN R.; DAI, DONGCHENG
To: SIGA TECHNOLOGIES, INC.,
Reel/Frame 033241/0049 →